Concepedia

Publication | Open Access

Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction

DOIFull Paper Access

95

Citations

22

References

2017

Year

Charlotte S. McCarroll, Weihong He, Kirsty Foote, Ashley Bradley, Karen McGlynn, Francesca Vidler, Colin Nixon, Katrin Nather, Caroline Fattah, Alexandra Riddell,
Circulation

Abstract

Our data identified Runx1 as a novel therapeutic target with translational potential to counteract the effects of adverse cardiac remodeling, thereby improving survival and quality of life among patients with MI.

References

YearCitations

Page 1